Melissa K Schaefer1, Joseph F Perz2. 1. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: mschaefer@cdc.gov. 2. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
OBJECTIVE: To summarize available information about outbreaks of infections stemming from drug diversion in US health care settings and describe recommended protocols and public health actions. PATIENTS AND METHODS: We reviewed records at the Centers for Disease Control and Prevention related to outbreaks of infections from drug diversion by health care personnel in US health care settings from January 1, 2000, through December 31, 2013. Searches of the medical literature published during the same period were also conducted using PubMed. Information compiled included health care setting(s), infection type(s), specialty of the implicated health care professional, implicated medication(s), mechanism(s) of diversion, number of infected patients, number of patients with potential exposure to blood-borne pathogens, and resolution of the investigation. RESULTS: We identified 6 outbreaks over a 10-year period beginning in 2004; all occurred in hospital settings. Implicated health care professionals included 3 technicians and 3 nurses, one of whom was a nurse anesthetist. The mechanism by which infections were spread was tampering with injectable controlled substances. Two outbreaks involved tampering with opioids administered via patient-controlled analgesia pumps and resulted in gram-negative bacteremia in 34 patients. The remaining 4 outbreaks involved tampering with syringes or vials containing fentanyl; hepatitis C virus infection was transmitted to 84 patients. In each of these outbreaks, the implicated health care professional was infected with hepatitis C virus and served as the source; nearly 30,000 patients were potentially exposed to blood-borne pathogens and targeted for notification advising testing. CONCLUSION: These outbreaks revealed gaps in prevention, detection, and response to drug diversion in US health care facilities. Drug diversion is best prevented by health care facilities having strong narcotics security measures and active monitoring systems. Appropriate response includes assessment of harm to patients, consultation with public health officials when tampering with injectable medication is suspected, and prompt reporting to enforcement agencies. Published by Elsevier Inc.
OBJECTIVE: To summarize available information about outbreaks of infections stemming from drug diversion in US health care settings and describe recommended protocols and public health actions. PATIENTS AND METHODS: We reviewed records at the Centers for Disease Control and Prevention related to outbreaks of infections from drug diversion by health care personnel in US health care settings from January 1, 2000, through December 31, 2013. Searches of the medical literature published during the same period were also conducted using PubMed. Information compiled included health care setting(s), infection type(s), specialty of the implicated health care professional, implicated medication(s), mechanism(s) of diversion, number of infectedpatients, number of patients with potential exposure to blood-borne pathogens, and resolution of the investigation. RESULTS: We identified 6 outbreaks over a 10-year period beginning in 2004; all occurred in hospital settings. Implicated health care professionals included 3 technicians and 3 nurses, one of whom was a nurse anesthetist. The mechanism by which infections were spread was tampering with injectable controlled substances. Two outbreaks involved tampering with opioids administered via patient-controlled analgesia pumps and resulted in gram-negative bacteremia in 34 patients. The remaining 4 outbreaks involved tampering with syringes or vials containing fentanyl; hepatitis C virus infection was transmitted to 84 patients. In each of these outbreaks, the implicated health care professional was infected with hepatitis C virus and served as the source; nearly 30,000 patients were potentially exposed to blood-borne pathogens and targeted for notification advising testing. CONCLUSION: These outbreaks revealed gaps in prevention, detection, and response to drug diversion in US health care facilities. Drug diversion is best prevented by health care facilities having strong narcotics security measures and active monitoring systems. Appropriate response includes assessment of harm to patients, consultation with public health officials when tampering with injectable medication is suspected, and prompt reporting to enforcement agencies. Published by Elsevier Inc.
Authors: Sara H Cody; Omana V Nainan; Richard S Garfein; Hildy Meyers; Beth P Bell; Craig N Shapiro; Emory L Meeks; Harriett Pitt; Eric Mouzin; Miriam J Alter; Harold S Margolis; Duc J Vugia Journal: Arch Intern Med Date: 2002-02-11
Authors: Tara M Vogt; Joseph F Perz; Clayton K Van Houten; Robert Harrington; Tia Hansuld; Stephanie R Bialek; Robert Johnston; Rachel Bratlie; Ian T Williams Journal: Addiction Date: 2006-05 Impact factor: 6.526
Authors: Belinda E Ostrowsky; Cynthia Whitener; Helen K Bredenberg; Loretta A Carson; Stacey Holt; Lori Hutwagner; Matthew J Arduino; William R Jarvis Journal: N Engl J Med Date: 2002-05-16 Impact factor: 91.245
Authors: D G Maki; B S Klein; R D McCormick; C J Alvarado; M A Zilz; S M Stolz; C A Hassemer; J Gould; A R Liegel Journal: JAMA Date: 1991-02-27 Impact factor: 56.272
Authors: Amy E Warner; Melissa K Schaefer; Priti R Patel; Jan Drobeniuc; Guoliang Xia; Yulin Lin; Yury Khudyakov; Candace W Vonderwahl; Lisa Miller; Nicola D Thompson Journal: Am J Infect Control Date: 2014-11-20 Impact factor: 2.918